We found that ADAR1, through its RNA binding domains (RBDs), binds/stabilizes CDK2 a key player in cancer cell-cycle progression, so promoting glioblastoma proliferation in vitro and most importantly in vivo. Here, CDK2 is linked to glioblastoma.